Tuccinardi, D., Farr, O. M., Upadhyay, J., Oussaada, S. M., Mathew, H., Paschou, S. A., . . . Mantzoros, C. S. (2019). Lorcaserin treatment decreases body weight and improves cardiometabolic risk factors of obese adults: A 6-month-long, randomized, placebo-controlled, double-blind clinical trial. Diabetes Obes Metab.
Citação norma ChicagoTuccinardi, Dario, et al. "Lorcaserin Treatment Decreases Body Weight and Improves Cardiometabolic Risk Factors of Obese Adults: A 6-month-long, Randomized, Placebo-controlled, Double-blind Clinical Trial." Diabetes Obes Metab 2019.
ציטוט MLATuccinardi, Dario, et al. "Lorcaserin Treatment Decreases Body Weight and Improves Cardiometabolic Risk Factors of Obese Adults: A 6-month-long, Randomized, Placebo-controlled, Double-blind Clinical Trial." Diabetes Obes Metab 2019.